Company: AEMD
Filing Date: 2025-07-25
Form Type: DRS
Source: 0001683168-25-005397
Chunk: 79

Company: AETHLON MEDICAL INC
Filing Date: 2025-07-25
Form: DRS
Chunk 79
---
FA by a relevant person which is:

| (a) | a corporation (which is not an accredited investor (as defined                                                                       
 in Section 4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one   
 or more individuals, each of whom is an accredited investor; or                                                                      |
| (b) | a trust (where the trustee is not an accredited investor) whose                                                                      
 sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor, securities (as 
 defined in Section 239(1) of the SFA) of that corporation or the beneficiaries’ rights and interest (howsoever described)            
 in that trust shall not be transferred within six months after that corporation or that trust has acquired the securities pursuant   
 to an offer made under Section 275 of the SFA except:                                                                                |
| (a) | to an institutional investor or to a relevant person defined in                                                                      
 Section 275(2) of the SFA, or to any person arising from an offer referred to in Section 275(1A) or Section 276(4)(i)(B)             
 of the SFA;                                                                                                                          |
| (b) | where no consideration is or will be given for the transfer;                                                                         |
| (c) | where the transfer is by operation of law;                                                                                           |
| (d) | as specified in Section 276(7) of the SFA; or                                                                                        |
| (e) | as specified in Regulation 32 of the Securities and Futures                                                                          
 (Offers of Investments) (Shares and Debentures) Regulations 2005 of Singapore.                                                       |

Notice to Prospective Investors in Canada

The securities may be sold
only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument
45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted
clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations.
Any resale of the securities must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus
requirements of applicable securities laws.

Securities legislation in certain
provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment
thereto) contains a